A day after one ARK Invest exchange-traded fund run by ETF star Cathie Wood parted with more than $11 million worth of Pfizer Inc. (NYSE: PFE) shares, that fund was back at it on Wednesday. Specifically, it sold over 140,000 more shares, as the price of this ETF pulled back over 4% in the day’s session. However, it is up a fair amount in the past year.
It was ARK Genomic Revolution ETF (NYSEARCA: ARKG) that shed 140,713 shares of Pfizer. At Wednesday’s closing price, this would have valued this sale at roughly $6.9 million. This is only a small fraction of the total holdings. The fund is up about 7% over the past 52 weeks.
Check out all the ARK Invest sales for Wednesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKG | CLLS | CELLECTIS | 8,300 |
| ARKG | PFE | PFIZER | 140,713 |
| ARKG | REGN | REGENERON PHARMACEUTICALS | 11,602 |
| ARKK | U | UNITY SOFTWARE | 113,490 |
| ARKQ | U | UNITY SOFTWARE | 15,700 |
| ARKW | U | UNITY SOFTWARE | 28,889 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
ALSO READ: Goldman Sachs Out With 10 Top Macro and Stock Market Themes for 2022
Get Our Free Investment Newsletter
Source: Read Full Article